Myeloid mDIC Deficiency Remodels Adipose Macrophages to an Efferocytosis-Associated State and Improves Metabolic Homeostasis During Obesity

Obesity-associated adipose inflammation contributes to metabolic dysfunction, yet the mechanisms linking mitochondrial metabolism to macrophage efferocytosis remain incompletely understood. The mitochondrial dicarboxylate carrier (mDIC), encoded by SLC25A10, regulates adipocyte function, but its role in macrophages remains unclear. Here, we investigated how myeloid mDIC deficiency affects mitochondrial function, macrophage heterogeneity, and metabolic homeostasis during diet-induced obesity. We observed reduced mDIC protein expression in subcutaneous white adipose tissue from individuals with obesity, whereas palmitate increased mDIC expression in mouse and human macrophages. Myeloid mDIC deletion preserved mitochondrial respiration under palmitate stress. Single-cell RNA sequencing of adipose stromal vascular cells from high-fat diet (HFD)-fed mice revealed an expanded efferocytosis-associated macrophage population and reduced proportions of inflammatory and lipid-associated macrophages. Consistently, mDIC-deficient macrophages exhibited increased Mertk expression and greater association with apoptotic cells. Pharmacological inhibition of mitochondrial ATP synthase or electron transport markedly suppressed apoptotic cell uptake, including the quenching-resistant fraction, without substantially affecting macrophage viability. In vivo, myeloid mDIC deletion attenuated HFD-induced weight gain, improved insulin sensitivity, and increased CD11c⁻CD206⁺ adipose macrophage abundance, accompanied by elevated expression of alternative activation-associated markers. Together, these findings identify myeloid mDIC as an important regulator of macrophage mitochondrial function and adipose immune remodeling during obesity, suggesting a novel mechanism by which mitochondrial bioenergetics contribute to macrophage apoptotic-cell handling and metabolic homeostasis.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.17.767460
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Myeloid mDIC Deficiency Remodels Adipose Macrophages to an Efferocytosis-Associated State and Improves Metabolic Homeostasis During Obesity

Qixiu Hou, Xinxin Ma, Alexandra Serrato, Juli Bai et al.
bioRxiv (Cold Spring Harbor Laboratory)
Adipokines, Inflammation, and Metabolic Diseases
preprint

Myeloid mDIC Deficiency Remodels Adipose Macrophages to an Efferocytosis-Associated State and Improves Metabolic Homeostasis During Obesity

Qixiu Hou, Xinxin Ma, Alexandra Serrato, Juli Bai, Phu M. Huynh, Yu A An, Yang Yang, Fenfen Wang
preprint en

Abstract

Obesity-associated adipose inflammation contributes to metabolic dysfunction, yet the mechanisms linking mitochondrial metabolism to macrophage efferocytosis remain incompletely understood. The mitochondrial dicarboxylate carrier (mDIC), encoded by SLC25A10, regulates adipocyte function, but its role in macrophages remains unclear. Here, we investigated how myeloid mDIC deficiency affects mitochondrial function, macrophage heterogeneity, and metabolic homeostasis during diet-induced obesity. We observed reduced mDIC protein expression in subcutaneous white adipose tissue from individuals with obesity, whereas palmitate increased mDIC expression in mouse and human macrophages. Myeloid mDIC deletion preserved mitochondrial respiration under palmitate stress. Single-cell RNA sequencing of adipose stromal vascular cells from high-fat diet (HFD)-fed mice revealed an expanded efferocytosis-associated macrophage population and reduced proportions of inflammatory and lipid-associated macrophages. Consistently, mDIC-deficient macrophages exhibited increased Mertk expression and greater association with apoptotic cells. Pharmacological inhibition of mitochondrial ATP synthase or electron transport markedly suppressed apoptotic cell uptake, including the quenching-resistant fraction, without substantially affecting macrophage viability. In vivo, myeloid mDIC deletion attenuated HFD-induced weight gain, improved insulin sensitivity, and increased CD11c⁻CD206⁺ adipose macrophage abundance, accompanied by elevated expression of alternative activation-associated markers. Together, these findings identify myeloid mDIC as an important regulator of macrophage mitochondrial function and adipose immune remodeling during obesity, suggesting a novel mechanism by which mitochondrial bioenergetics contribute to macrophage apoptotic-cell handling and metabolic homeostasis.

bioRxiv (Cold Spring Harbor Laboratory)
The University of Texas Health Science Center at Houston (US)
American Diabetes Association
Good health and well-being
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon